At the request of ChromoGenics AB, ChromoGenics equity rights will be traded on First North as from February 13, 2018.
|Security name:||ChromoGenics TO2|
|Short name:||CHRO TO2|
|Terms:||Issue price, SEK 3,50 per share|
One (1) option right gives the right to subscribe for
one (1) new share in ChromoGenics AB (publ)
|Subscription period:||January 10, 2020 - January 31, 2020|
|Last trading day:||January 29, 2020|
This information is distributed at the request of the Certified Adviser, G&W Fondkommission. For further information, please call G&W Fondkommission AB on +46 8 503 000 50.